Related Experiment Videos

A modified directional atherectomy catheter for resection of calcified atherosclerotic plaques

M K Hong1, S C Wong, G S Mintz

  • 1Department of Internal Medicine, Washington Hospital Center, Washington, DC, USA.

Abstract

Insights

A modified directional coronary atherectomy catheter effectively removed calcified plaques in human arteries. This novel device shows promise for treating calcified coronary lesions, especially in larger vessels.

Area of Science:

  • Cardiovascular Interventions
  • Medical Device Engineering
  • Atherosclerosis Research

Background:

  • Atherosclerotic plaques, particularly calcified ones, pose challenges in cardiovascular interventions.
  • Current atherectomy devices may have limitations in effectively resecting calcified material.

Purpose of the Study:

  • To assess the feasibility of resecting calcified atherosclerotic plaques using a modified directional coronary atherectomy (DCA) catheter.
  • To compare the performance of the modified DCA catheter against a conventional one in simulated and ex-vivo models.

Main Methods:

  • A conventional DCA catheter was modified with a tungsten carbide blade and enhanced drive cable strength.
  • Performance was evaluated using an in-vitro sea coral model and ex-vivo human arteries with calcification.
  • Intravascular ultrasound and histologic examination confirmed atherectomy effectiveness.

Main Results:

  • The modified DCA catheter resected significantly more simulated calcified material (coral) than the conventional catheter.
  • It demonstrated greater effectiveness in removing calcified plaques from ex-vivo human arteries.
  • Intravascular ultrasound showed reduced residual stenosis with the modified device compared to the conventional one.

Conclusions:

  • The modified DCA catheter successfully resected both calcified and non-calcified plaques in ex-vivo human arteries.
  • This modification proves the feasibility of directional coronary atherectomy for calcified plaques.
  • The enhanced catheter holds potential for treating calcified coronary lesions, particularly in larger vessels.

Related Concept Videos